small molecule

SKLICE

IVERMECTIN

Loss of exclusivityloss of exclusivity
CompanyARBOR PHARMACEUTICALS LLC

Drug detail

Brand nameSKLICE
Active ingredientIVERMECTIN
Strength0.5%
Dosage formLOTION
RouteTOPICAL
ModalitySmall molecule
FDA approvalFebruary 2012
Marketing statusOTC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

SKLICE patent cliff — loss of exclusivity — | CliffBio